133 related articles for article (PubMed ID: 621612)
1. Chlorambucil dosage in frequently relapsing nephrotic syndrome: a controlled clinical trial.
Baluarte HJ; Hiner L; Gruskin AB
J Pediatr; 1978 Feb; 92(2):295-8. PubMed ID: 621612
[TBL] [Abstract][Full Text] [Related]
2. Chlorambucil treatment of frequently relapsing nephrotic syndrome.
Grupe WE; Makker SP; Ingelfinger JR
N Engl J Med; 1976 Sep; 295(14):746-9. PubMed ID: 958261
[TBL] [Abstract][Full Text] [Related]
3. Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide.
Bailey RR
N Z Med J; 1989 Jul; 102(872):379-81. PubMed ID: 2797556
[TBL] [Abstract][Full Text] [Related]
4. Chlorambucil in steroid-dependent nephrotic syndrome.
Grupe WE
J Pediatr; 1973 Apr; 82(4):598-606. PubMed ID: 4121460
[No Abstract] [Full Text] [Related]
5. Long-term evaluation of chlorambucil plus prednisone in the idiopathic nephrotic syndrome of childhood.
Williams SA; Makker SP; Ingelfinger JR; Grupe WE
N Engl J Med; 1980 Apr; 302(17):929-33. PubMed ID: 6987521
[TBL] [Abstract][Full Text] [Related]
6. Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence.
Arbeitsgemeinschaft für Pädiatrische Nephrologie
N Engl J Med; 1982 Feb; 306(8):451-4. PubMed ID: 7035953
[TBL] [Abstract][Full Text] [Related]
7. Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology.
Niaudet P
Pediatr Nephrol; 1992 Jan; 6(1):1-3. PubMed ID: 1536727
[TBL] [Abstract][Full Text] [Related]
8. Chlorambucil therapy in childhood nephrotic syndrome.
Wiggelinkhuizen J; McDonald R; van Dugteren GR
S Afr Med J; 1979 Jun; 55(24):971-5. PubMed ID: 472947
[TBL] [Abstract][Full Text] [Related]
9. Controlled trial of chlorambucil in frequently relapsing nephrotic syndrome in children (a preliminary report).
Alatas H; Wirya IG; Tambunan T; Himawan S
J Med Assoc Thai; 1978 Jan; 61 Suppl 1():222-8. PubMed ID: 342654
[No Abstract] [Full Text] [Related]
10. [Verification of indications for kidney biopsy in children with steroid-dependent nephrotic syndrome].
Idczak-Nowicka E; Ksiazek J; Kryński J; Wyszyńska T
Pediatr Pol; 1996 Aug; 71(8):679-83. PubMed ID: 8927471
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of nephrotic syndrome in children (author's transl)].
Schärer K
Monatsschr Kinderheilkd; 1980 Nov; 128(11):685-8. PubMed ID: 6110172
[TBL] [Abstract][Full Text] [Related]
12. Non-corticosteroid treatment for nephrotic syndrome in children.
Durkan A; Hodson E; Willis N; Craig J
Cochrane Database Syst Rev; 2001; (4):CD002290. PubMed ID: 11687155
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of cyclophosphamide therapy in frequent relapsing minimal lesion nephrotic syndrome.
Chiu J; Drummond KN
J Pediatr; 1974 Jun; 84(6):825-30. PubMed ID: 4855503
[No Abstract] [Full Text] [Related]
14. A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children.
Latta K; von Schnakenburg C; Ehrich JH
Pediatr Nephrol; 2001 Mar; 16(3):271-82. PubMed ID: 11322378
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
Idasiak-Piechocka I; Oko A; Łochyńska-Bielecka K; Skrobańska B
Kidney Blood Press Res; 2009; 32(4):263-7. PubMed ID: 19776643
[TBL] [Abstract][Full Text] [Related]
16. Linear growth of children with nephrotic syndrome: effect of alkylating agents.
Padilla R; Brem AS
Pediatrics; 1989 Sep; 84(3):495-9. PubMed ID: 2771553
[TBL] [Abstract][Full Text] [Related]
17. Long-term assessment of chlorambucil in children with nephrotic syndrome who fail to respond adequately to corticosteroids.
Pascual JF; Molina M; Lopez J
Contrib Nephrol; 1981; 27():65-74. PubMed ID: 7285590
[No Abstract] [Full Text] [Related]
18. Alternate-day versus intermittent prednisone in frequently relapsing nephrotic syndrome. A report of "Arbetsgemeinschaft für Pädiatrische Nephrologie".
Lancet; 1979 Feb; 1(8113):401-3. PubMed ID: 84259
[TBL] [Abstract][Full Text] [Related]
19. Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents.
Griswold WR; Tune BM; Reznik VM; Vazquez M; Prime DJ; Brock P; Mendoza SA
Nephron; 1987; 46(1):73-7. PubMed ID: 3600915
[TBL] [Abstract][Full Text] [Related]
20. Three-monthly bolus vitamin D supplements (1000 vs 400 IU/day) for prevention of bone loss in children with difficult-to-treat nephrotic syndrome: a randomised clinical trial.
Singh DN; Krishnamurthy S; Kamalanathan SK; Harichandrakumar KT; Sivamurukan P
Paediatr Int Child Health; 2018 Nov; 38(4):251-260. PubMed ID: 30092157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
